annual CFF:
$57.84M-$273.17M(-82.53%)Summary
- As of today (May 30, 2025), AXSM annual cash flow from financing activities is $57.84 million, with the most recent change of -$273.17 million (-82.53%) on December 31, 2024.
- During the last 3 years, AXSM annual CFF has risen by +$46.71 million (+419.68%).
- AXSM annual CFF is now -82.53% below its all-time high of $331.01 million, reached on December 31, 2023.
Performance
AXSM Cash from financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFF:
$29.27M+$15.03M(+105.49%)Summary
- As of today (May 30, 2025), AXSM quarterly cash flow from financing activities is $29.27 million, with the most recent change of +$15.03 million (+105.49%) on March 31, 2025.
- Over the past year, AXSM quarterly CFF has increased by +$30.46 million (+2565.88%).
- AXSM quarterly CFF is now -88.11% below its all-time high of $246.08 million, reached on June 30, 2023.
Performance
AXSM quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
$88.30M+$30.46M(+52.66%)Summary
- As of today (May 30, 2025), AXSM TTM cash flow from financing activities is $88.30 million, with the most recent change of +$30.46 million (+52.66%) on March 31, 2025.
- Over the past year, AXSM TTM CFF has dropped by -$189.96 million (-68.27%).
- AXSM TTM CFF is now -81.44% below its all-time high of $475.66 million, reached on June 30, 2023.
Performance
AXSM TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AXSM Cash from financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -82.5% | +2565.9% | -68.3% |
| 3 y3 years | +419.7% | -5.9% | +158.2% |
| 5 y5 years | -77.1% | +4547.5% | -58.9% |
AXSM Cash from financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -82.5% | +419.7% | -88.1% | +2565.9% | -81.4% | +158.2% |
| 5 y | 5-year | -82.5% | +419.7% | -88.1% | +2565.9% | -81.4% | +693.3% |
| alltime | all time | -82.5% | +1456.0% | -88.1% | +2565.9% | -81.4% | >+9999.0% |
AXSM Cash from financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $29.27M(+105.5%) | $88.30M(+52.7%) |
| Dec 2024 | $57.84M(-82.5%) | $14.24M(-53.2%) | $57.84M(+32.7%) |
| Sep 2024 | - | $30.41M(+111.5%) | $43.59M(-6.4%) |
| Jun 2024 | - | $14.38M(-1311.3%) | $46.56M(-83.3%) |
| Mar 2024 | - | -$1.19M(>+9900.0%) | $278.26M(-15.9%) |
| Dec 2023 | $331.01M(+16.3%) | -$2000.00(-100.0%) | $331.01M(-0.3%) |
| Sep 2023 | - | $33.37M(-86.4%) | $332.08M(-30.2%) |
| Jun 2023 | - | $246.08M(+377.2%) | $475.66M(+55.9%) |
| Mar 2023 | - | $51.56M(+4737.2%) | $305.05M(+7.2%) |
| Dec 2022 | $284.58M(+2456.9%) | $1.07M(-99.4%) | $284.58M(+0.1%) |
| Sep 2022 | - | $176.95M(+134.5%) | $284.21M(+163.9%) |
| Jun 2022 | - | $75.46M(+142.6%) | $107.70M(+214.9%) |
| Mar 2022 | - | $31.10M(+4402.3%) | $34.20M(+207.3%) |
| Dec 2021 | $11.13M(-73.8%) | $690.80K(+57.5%) | $11.13M(-11.2%) |
| Sep 2021 | - | $438.70K(-77.7%) | $12.53M(-68.3%) |
| Jun 2021 | - | $1.97M(-75.4%) | $39.52M(-20.7%) |
| Mar 2021 | - | $8.03M(+284.2%) | $49.81M(+17.4%) |
| Dec 2020 | $42.41M(-83.2%) | $2.09M(-92.4%) | $42.41M(-81.9%) |
| Sep 2020 | - | $27.43M(+123.6%) | $234.22M(+13.0%) |
| Jun 2020 | - | $12.27M(+1847.5%) | $207.31M(-3.5%) |
| Mar 2020 | - | $629.80K(-99.7%) | $214.86M(-14.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $252.39M(+2415.3%) | $193.89M(>+9900.0%) | $252.39M(+276.5%) |
| Sep 2019 | - | $518.80K(-97.4%) | $67.04M(-0.4%) |
| Jun 2019 | - | $19.82M(-48.0%) | $67.31M(+37.7%) |
| Mar 2019 | - | $38.16M(+346.7%) | $48.88M(+387.2%) |
| Dec 2018 | $10.03M(-58.0%) | $8.54M(+981.5%) | $10.03M(-1.0%) |
| Sep 2018 | - | $789.80K(-43.4%) | $10.13M(+7.0%) |
| Jun 2018 | - | $1.40M(-301.3%) | $9.47M(+16.2%) |
| Mar 2018 | - | -$693.40K(-108.0%) | $8.15M(-65.9%) |
| Dec 2017 | $23.88M(+139.6%) | $8.64M(+6550.5%) | $23.88M(-5.2%) |
| Sep 2017 | - | $129.90K(+73.7%) | $25.20M(+0.5%) |
| Jun 2017 | - | $74.80K(-99.5%) | $25.08M(+0.3%) |
| Mar 2017 | - | $15.04M(+51.1%) | $25.01M(+150.9%) |
| Dec 2016 | $9.97M(-81.1%) | $9.95M(>+9900.0%) | $9.97M(-78.2%) |
| Sep 2016 | - | $14.70K(>+9900.0%) | $45.69M(-0.3%) |
| Jun 2016 | - | $0.00(-100.0%) | $45.80M(-13.4%) |
| Dec 2015 | $52.88M(+931.5%) | $45.67M(>+9900.0%) | $52.88M(+633.7%) |
| Sep 2015 | - | $133.50K(-98.0%) | $7.21M(+1.9%) |
| Jun 2015 | - | $6.83M(+2726.7%) | $7.07M(+2826.7%) |
| Mar 2015 | - | $241.70K | $241.70K |
| Dec 2014 | $5.13M(+37.9%) | - | - |
| Dec 2013 | $3.72M | - | - |
FAQ
- What is Axsome Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Axsome Therapeutics?
- What is Axsome Therapeutics annual CFF year-on-year change?
- What is Axsome Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Axsome Therapeutics?
- What is Axsome Therapeutics quarterly CFF year-on-year change?
- What is Axsome Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Axsome Therapeutics?
- What is Axsome Therapeutics TTM CFF year-on-year change?
What is Axsome Therapeutics annual cash flow from financing activities?
The current annual CFF of AXSM is $57.84M
What is the all time high annual CFF for Axsome Therapeutics?
Axsome Therapeutics all-time high annual cash flow from financing activities is $331.01M
What is Axsome Therapeutics annual CFF year-on-year change?
Over the past year, AXSM annual cash flow from financing activities has changed by -$273.17M (-82.53%)
What is Axsome Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of AXSM is $29.27M
What is the all time high quarterly CFF for Axsome Therapeutics?
Axsome Therapeutics all-time high quarterly cash flow from financing activities is $246.08M
What is Axsome Therapeutics quarterly CFF year-on-year change?
Over the past year, AXSM quarterly cash flow from financing activities has changed by +$30.46M (+2565.88%)
What is Axsome Therapeutics TTM cash flow from financing activities?
The current TTM CFF of AXSM is $88.30M
What is the all time high TTM CFF for Axsome Therapeutics?
Axsome Therapeutics all-time high TTM cash flow from financing activities is $475.66M
What is Axsome Therapeutics TTM CFF year-on-year change?
Over the past year, AXSM TTM cash flow from financing activities has changed by -$189.96M (-68.27%)